StockData
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) stock

GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.27−0.08 (-5.95%)

Close on Nov 18, 2026Market cap $2.78MP/E –Yield –

GRI Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

GRI Bio's market cap was $4.00M on Nov 11, 2026, against $183.07M a year earlier. Over the last 5 years it ranged from $956.53K to $311.64B, with a median of $1.63B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.00M-82.3%
2025Dec 31, 2025$22.59M-98.9%
2024Dec 31, 2024$1.98B-71.9%
2023Dec 29, 2023$7.04B-69.2%
2022Dec 30, 2022$22.86B-90.9%
2021Dec 31, 2021$252.18B–

More GRI Bio figures

See a number that looks wrong?